Considering the timing of GLP-1RAs initiation after bariatric surgery, recent studies indicate that the proper healing and metabolic adaptations that occur following bariatric procedures, such as changes in gut hormones and insulin sensitivity, may play a role in the effectiveness of GLP-1RAs [73]
Because of their glucose lowering effects, therapies that enhance incretin actions through inhibiting degradation of endogenous incretins or through activation of the GLP-1 receptor are now in use for the treatment of type 2 diabetes
Promotes healthy weight loss management
Thats why we actively seek out or independently develop products which conform to the latest findings, and guarantee patients long-term use without side effects impacting their health. 75 g (50,4 g L-Carnitine)
Important: If you are sensitive to caffeine or already consume other caffeine sources (coffee, energy drinks), adjust your intake according to your daily tolerance
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications